跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Approvals
/
Health Canada
/
HAMOL
Authorized
STANDARD
HAMOL
ak-pak ricci
🇨🇦 Health Canada
Approval Date
Jul 4, 2025
Approval ID
35d8cb375490b882
Company
ak-pak ricci
Type
Standard
Approval Details
Approval Id
35d8cb375490b882
Drug Approval Canada Name
HAMOL
Product Name
HAMOL
Status
Cancelled Post Market
Status Date
2022-01-01
Original Market Date
2020-11-27
Din
02500604
Drug Class
Human
Dosage Form
Gel
Route Of Administration
Topical (Household)
Schedule
OTC
Ahfs
84:04.92
Atc Original
D08AJ01 BENZALKONIUM
Atc Name
d 08 aj 01
Aig Number
0104993016
Company Name
ak-pak ricci
Company Address
7600 Rte. Transcanadienne, St-Laurent, Quebec, Canada, H4T 1A5
Active Ingredients
BENZALKONIUM CHLORIDE
0.13 % / W/W
Authorized
Quick Info
Agency
Health Canada
Country
🇨🇦
Approval Date
Jul 4, 2025
Approval ID
35d8cb375490b882
Type
Standard
Back to Health Canada Approvals
HAMOL - Health Canada Drug Approval Details